silybin has been researched along with Atypical Lipomatous Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becerikli, M; Behr, B; Daigeler, A; Harati, A; Harati, K; Hirsch, T; Jacobsen, F; Lehnhardt, M; Renner, M; Wallner, C | 1 |
1 other study(ies) available for silybin and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Fibrosarcoma; Humans; Liposarcoma; Sarcoma; Sarcoma, Synovial; Silybin; Silymarin | 2017 |